Pharmacy Daily | PharmX and CH2 position for growth

PHARMACY ordering platform PharmX has expanded its partnership with CH2, a Community Service Obligation wholesaler and part of Paragon Care Limited.

The collaboration is set to deepen pharmacy engagement and the use of market intelligence for data-driven growth across Australia's healthcare sector.

The partnership builds on PharmX's role as a key provider of the PharmX Gateway, an electronic data interchange solution that handles orders for 99% of Australian pharmacies.

Now, the alliance will include PharmX's full suite of solutions, with CH2 broadening its product range on PharmX's marketplace.

This addition will bring over 10,000 products from 500 brands to meet the expanding needs of pharmacies nationwide.

Additionally, PharmX will aim to support CH2's growth through tailored analytics and predictive demand insights.

PharmX CEO Tom Culver expressed enthusiasm for the expanded partnership, stating, "we're excited to strengthen our relationship with CH2 by offering our extended service portfolio that brings even greater value to our various partners".

"Expanding CH2's product range across our marketplace strengthens our service offering and provides more accurate information on pricing and stock, which we know are highly valued by our pharmacy customers."

CH2 CEO David Collins highlighted the significance of the expanded agreement, noting, "this partnership not only strengthens our engagement with existing customers but also allows us to connect with new pharmacies across Australia, reinforcing the company's commitment to providing comprehensive, innovative solutions for the healthcare community."

The alliance reflects PharmX's and CH2's shared vision for growth, and aims to position both companies for long-term success in Australia's evolving healthcare landscape. JG